Medical Foods Market Size

ID: MRFR/Pharma/3484-CR

128 Pages

Rahul Gotadki

June 2023

Medical Foods Market Research Report Information By Nutritional Ingredients (Vitamins and Minerals, Proteins, Omega-3, Isoflavones, Phytosterols, and Others) by Route of Administration (Oral and Enteral) By Form (Pills, Powder, and Others) by Application (Chronic Kidney Disease, Nutritional Deficiency, Neurological & Psychological Disorders, Metabolic Disorders, Pain Management, Gastrointes...

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Download PDF

Medical Foods Size

Medical Foods Market Growth Projections and Opportunities

The escalating demand for medical foods is spurred by the surging incidence of chronic diseases worldwide, necessitating specialized dietary management. Nutritional deficiencies, affecting nearly a third of the global population, contribute to the market's growth. However, a challenge lies in the limited awareness surrounding medical foods. On a positive note, continuous innovation and frequent product launches by industry leaders present an opportunity for market expansion. These initiatives demonstrate a commitment to addressing evolving healthcare needs and preferences, positioning the global medical foods market for sustained growth. As the prevalence of chronic diseases rises globally, the demand for medical foods intensifies, addressing unique nutritional needs in disease management. Widespread nutritional deficiencies affecting a significant portion of the global population further drive market growth. Despite these positive trends, limited awareness poses a challenge to market expansion. On a brighter note, continuous innovation and frequent product launches by industry leaders not only showcase a commitment to evolving healthcare requirements but also create avenues for market opportunity. This dynamism positions the global medical foods market for sustained growth and relevance in addressing the evolving health landscape.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per Market Research Future Analysis, the Global Medical Foods Market was valued at USD 22.62 billion in 2023 and is projected to reach USD 35.3 billion by 2032, growing at a CAGR of 4.92% from 2024 to 2032. The market growth is driven by the rising prevalence of chronic diseases, increasing nutritional deficiencies, and heightened awareness of prebiotic and probiotic products. The market is characterized by a significant demand for specialized dietary management solutions, particularly for conditions like diabetes and neurological disorders. The North American region holds the largest market share, attributed to the high incidence of chronic diseases and a well-established healthcare infrastructure.

Key Market Trends & Highlights

Key trends influencing the Medical Foods Market include the following:

The market is expected to grow from USD 24.04 billion in 2024 to USD 35.3 billion by 2032. Chronic diseases, including diabetes and cardiovascular issues, are driving demand for medical foods. The nutritional deficiency segment dominated the market in 2022, with neurological disorders projected as the fastest-growing application. The e-commerce distribution channel is anticipated to be the fastest-growing segment during the forecast period.

Market Size & Forecast

2023 Market Size	USD 22.62 Billion
2024 Market Size	USD 24.04 Billion
2032 Market Size	USD 35.3 Billion
CAGR (2024-2032)	4.92%
Largest Regional Market Share in 2022	North America.

Major Players

Key players in the market include Nestlé (Switzerland), Danone SA (France), Abbott (US), and Fresenius Kabi AG (Germany).

Market Trends

The increasing prevalence of chronic diseases boosts the market growth

Chronic diseases such as cardiovascular, neurological, urological, and infectious diseases are increasing globally. Heart disorders are becoming more common than other chronic diseases due to a lack of physical activity, being overweight, poor nutrition, or having a family history. People over the age of 60 are at a higher risk of developing diseases such as cardiovascular and neurological issues. In addition, some people with these conditions or diseases must undergo surgery. Therefore, an increase in cardiovascular and neurological issues is expected to boost the demand for medical foods.

Diabetes is one of the most common chronic illnesses, and its incidence is steadily increasing. For instance, according to World Health Organization (WHO) statistics released in 2019, diabetes is responsible for roughly 1.5 million deaths and is the ninth top cause of death. Moreover, rising interest in medical foods to manage and regulate diabetic neuropathy and diabetes is anticipated to drive market development. Furthermore, medicinal foods are meant for specialized dietary management with unique nutrient needs to address specific illnesses, which will drive the market

The world has made some progress toward achieving its nutritional objectives. Severe starvation still remains, and this development is simply too sluggish.

Furthermore, few nations such as Somalia, Central African Republic, and Yemen among others are on track to achieve any of the maternal, infant, and young child nutrition (MIYCN) targets. According to the global nutrition report 2021, only five nations such as Ethiopia, Rwanda, Uganda, Tanzania, and Ghana on track to lower the prevalence of anemia among women of reproductive age, with one in three (29.9%) of these women, particularly those who are pregnant, being affected. Also, as per the same report, an estimated 14.6% of infants worldwide have low birth weight.

Thus, increasing rates of malnutrition in infants and young children and the rising prevalence of coexisting stunting, wasting, and overweight in children under 5 years of age across the globe will contribute to the growth of the market.

Prevalence of stunting, wasting, and overweight in children under 5 years of age

The Global Medical Foods Market is poised for growth as healthcare systems increasingly recognize the therapeutic potential of specialized nutritional products in managing chronic conditions and enhancing patient outcomes.

U.S. Food and Drug Administration (FDA)

Medical Foods Market Market Drivers

Growing Aging Population

The Global Global Medical Foods Market Industry is significantly influenced by the growing aging population, which often requires specialized nutritional support. As individuals age, their nutritional needs change, leading to an increased demand for medical foods that cater to conditions such as malnutrition and cognitive decline. According to the United Nations, the global population aged 60 years and older is projected to reach 2.1 billion by 2050. This demographic shift is likely to drive the market, as healthcare providers increasingly recognize the importance of tailored nutrition in improving health outcomes for older adults.

Market Growth Projections

The Global Global Medical Foods Market Industry is projected to experience substantial growth, with estimates indicating a market value of 24.0 USD Billion in 2024 and a potential increase to 40.8 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 4.92% from 2025 to 2035, reflecting the increasing demand for specialized nutritional products across various healthcare settings. The expansion of the market is likely to be driven by factors such as the rising prevalence of chronic diseases, an aging population, and advancements in food technology, positioning medical foods as a critical component of modern healthcare.

Regulatory Support and Guidelines

The Global Global Medical Foods Market Industry is supported by regulatory frameworks and guidelines that promote the use of medical foods in clinical settings. Governments and health organizations are increasingly recognizing the importance of medical foods in managing various health conditions, leading to the establishment of clear regulations that govern their production and marketing. This regulatory support not only enhances consumer confidence but also encourages manufacturers to invest in research and development. As a result, the market is expected to flourish, with a growing number of products entering the marketplace to meet the evolving needs of healthcare providers and patients.

Rising Prevalence of Chronic Diseases

The Global Global Medical Foods Market Industry is experiencing growth driven by the increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and obesity. As healthcare systems worldwide grapple with these conditions, there is a heightened demand for specialized nutritional products that can aid in managing these diseases. For instance, the World Health Organization indicates that chronic diseases account for a significant portion of global mortality, prompting healthcare providers to recommend medical foods as part of treatment plans. This trend is expected to contribute to the market's expansion, with projections estimating a market value of 24.0 USD Billion in 2024.

Increased Awareness of Nutritional Therapy

The Global Global Medical Foods Market Industry is benefiting from increased awareness of nutritional therapy among healthcare professionals and patients alike. As research continues to highlight the role of nutrition in disease management, medical foods are gaining recognition as essential components of treatment protocols. Healthcare providers are increasingly recommending these products to enhance patient care, particularly in managing chronic conditions. This growing acceptance is expected to propel the market forward, with a projected compound annual growth rate of 4.92% from 2025 to 2035, reflecting a shift towards more integrated approaches to health and wellness.

Technological Advancements in Food Science

The Global Global Medical Foods Market Industry is poised for growth due to technological advancements in food science, which enhance the formulation and delivery of medical foods. Innovations in processing techniques, ingredient sourcing, and product development are enabling manufacturers to create more effective and palatable medical foods. For example, advancements in biotechnology have led to the development of specialized proteins and nutrients that cater to specific health needs. This evolution in product offerings is likely to attract a broader consumer base, contributing to the market's projected value of 40.8 USD Billion by 2035.

Market Segment Insights

Medical Foods Nutritional Ingredients Insights

The Medical Foods Market segmentation, based on nutritional ingredients, includes vitamins and minerals, proteins, omega-3, isoflavones, phytosterols, and others. The proteins segment held the majority share in 2022 in the Medical Foods Market revenue. This is due to rising public awareness of children’s nutrition, rising protein functionalities, and awareness about protein-rich diets. Moreover, proteins are required for the body's proper functioning. They serve as the foundation for body structures like skin and hair, as well as other substances like enzymes, cytokines, and antibodies.

January 2023: Danone SA (France), has launched Fortimel PlantBased Energy, it is first plant-based, ready-to-drink nutritional supplement formula ready-to-drink to comply with the needs of those who are undernourished or at risk of becoming undernourished as a result of illness.

Medical Foods Route of Administration Insights

The Medical Foods Market segmentation, based on the route of administration, includes oral and enteral. The oral segment held the majority share in 2022 in the Medical Foods Market revenue. This is due to an increase in the production of oral products in the form of pills, powder, and pre-thickened products. For instance, Modulen, a medical food item offered by Nestle (Switzerland) is helpful in restoring the nutritional requirements in Crohn's disease patients.

Medical Foods Form Insights

The Medical Foods Market segmentation, based on Form, includes pills, powder, and others. The powder segment held the majority share in 2022 in the Medical Foods Market revenue. This is due to availability in the market and the increasing preference and ease of consumption of pediatric and geriatric patients suffering from various chronic diseases. Additionally, the growing advantages of consuming liquid-formulated foods to maintain adequate hydration and electrolyte balance support the segment's expansion.

Medical Foods Application Insights

The Medical Foods Market segmentation is based on an application that includes, chronic kidney disease, nutritional deficiency, neurological & psychological disorders, metabolic disorders, pain management, gastrointestinal disorders, orphan diseases, and others. The nutritional deficiency segment has dominated the market in 2022 and the neurological & psychological disorders segment is projected to be the fastest-growing during the forecast period, 2022–2030. This is attributed to the increasing prevalence of acute and chronic disorders, the need for more research and development activities, and the rising demand for vitamin D and vitamin B complex due to their health benefits.

Furthermore, neurological & psychological disorders cover a wide range of illnesses and conditions, including anxiety, depression, schizophrenia, dementia, Alzheimer’s disease, substance abuse disorders, and others.

Figure 2: MEDICAL FOODS MARKET, BY APPLICATION, 2023 & 2032 (USD Billion)

Medical Foods Distribution Channel Insights

The Medical Foods Market segmentation is based on a distribution channel that includes e-commerce, hospital pharmacies, Retail Pharmacies, and Others. The hospital pharmacies segment has dominated the market in 2022 and the e-commerce segment is projected to be the fastest-growing during the forecast period, 2022–2030. This is due to the growing number of patient visits to hospitals and the increasing preference among patients to consult a doctor in the hospitals for their chronic diseases.

In addition, e-commerce distribution is expected to be the most profitable channel owing to the rising e-commerce platforms, such as Amazon, Walmart, and online pharmacies are assisting products in expanding globally through simple buy, sell, and quick delivery strategies. Furthermore, the expansion of both public and private healthcare facilities as well as an increase in the number of people with chronic diseases worldwide will support the segment's expansion.

August 2020: Nestlé (Switzerland) acquired a range of products from IM HealthScience, (US) including its brands IBgard, FDgard, Fiber Choice, and REMfresh. With this acquisition, The IMH products offer a variety of sleep management techniques as well as tried-and-true methods for using diet to treat particular intestinal issues.

Get more detailed insights about Medical Foods Market Research Report- Forecast till 2032

Regional Insights

By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North American medical foods market accounted for the largest market share in 2022. This is due to the increasing prevalence of chronic diseases such as diabetes, cancer, cardiovascular disorders, and others, the rise in the adoption of medical foods in the region, and the rising strategic partnership and increasing investment by major players in the region.

For instance, in 2020, as per the National Cancer Institute, the National Institutes of Health forecasted an estimated 1,806,590 new cases of cancer to be diagnosed in the US, with about 606,520 deaths reported as a result of the disease. Moreover, the rising prevalence of cancer, diabetes, and other chronic disorders demands personalized nutrition for the management of diseases. In addition, the well-established healthcare infrastructure and rising demand for personalized nutrition also contribute to the growth of the market.

Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: MEDICAL FOODS MARKET BY REGION 2023 & 2032

MEDICAL FOODS MARKET

Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

Europe medical foods market accounts for the second-largest market share due to the increasing awareness of the benefits of medical foods, the growing development of new formulations, such as plant-based proteins & probiotics, and the rising aging population. further, the Germany medical foods market was attributed to holding the largest market share, and the France medical foods market is expected to fastest-growing market in the European region.

The Asia-Pacific medical foods market is expected to grow at a significant share from 2023 to 2030. This is due to the improving healthcare infrastructure, rising geriatric population & diseases associated with old age, and growing health awareness among the population in the Asia-Pacific region. Moreover, China medical foods market is expected to hold the largest market share, and India medical foods market is expected fastest-growing market in the Asia-Pacific region.

For instance, the Indian government’s initiative 'National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke', aims to promote healthy lifestyles and provide affordable healthcare for people with chronic diseases. Hence, the rising government initiatives and growing aging population factors are likely to have considerable growth for the medical foods market.

The Rest of the World is segmented into the Middle East, Africa, and Latin America. The medical foods market in the above-mentioned regions is likely to witness growth due to improving healthcare facilities, the growing availability of medical food products, and the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders in these regions. Moreover, an increase in sedentary lifestyles, urbanization, and changes in dietary habits has led to a growing demand for medical foods to manage chronic diseases and improve overall health is expected to propel the medical foods market growth in the region.

Key Players and Competitive Insights

The Medical Foods Market is characterized by the presence of many global, regional, and local vendors catering to the demand created by research scientists and pharmaceutical and biotechnology companies operating in the industry. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reach across the globe with diverse product portfolios. Companies such as Nestlé (Switzerland), Danone SA (France), Abbott (US), and Fresenius Kabi AG (Germany) dominate the Medical Foods Market due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are focused on investing in research and development.

Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.

One of the primary business strategies adopted by manufacturers in the global medical foods industry to benefit clients and expand the medical foods market sector is to manufacture locally to reduce operating costs.

Nestlé (Switzerland) produces and sells food products and beverages. It sells infant foods, bottled water, cereals, chocolates, candy, coffee, kitchenware, chilled and frozen foods, dairy, ice cream, and accessories for animals. The business also offers direct-to-consumer meal delivery services, medical foods, sausages, and nutritional products. Furthermore, the company operates in North America, Europe, Asia, Oceania, Africa, and the Middle East. For instance, in January 2023, Nestlé (India) launched ThickenUp Clear, a food and beverage thickener to treat patients with swallowing difficulties, especially in oropharyngeal dysphagia.

Also, Abbott (US) is a leading healthcare company that is engaged in the development, discovers, manufactures, and sells healthcare products across the globe. The company offers products under the segments of vascular products, established pharmaceutical products, nutritional products, and diagnostic products. Furthermore, it has two non-reportable segments, namely, medical optics and diabetes care. Moreover, Abbott distributes its products in more than 160 countries.

Industry Developments

July 2022: Nestlé (Switzerland) introduced the first Foods for Special Medical Purpose (FSMP) Oral Impact Su Yi Su for patients with Tumor-related conditions.

January 2020: Nestlé (Switzerland) acquired Zenpep (US) to expand its medical nutrition business and complement its portfolio of therapeutic products.

October 2019: Fresenius Kabi AG (Germany) has expanded of its plant in Aquiraz, Brazil to increase the facility’s capacity for parenteral nutrition production by around 30 percent.

December 2022: Abbott (US) announced its new factory for making specialty and nutritional powder products in Bowling Green, Ohio. This plant will enhance the availability of these crucial formulations in the US, some of which are the only source of nutrition for those with severe food allergies and other nutritional and metabolic issues.

Future Outlook

Medical Foods Market Future Outlook

The Global Medical Foods Market is projected to grow at a 4.92% CAGR from 2024 to 2032, driven by increasing chronic diseases, aging populations, and advancements in nutritional science.

New opportunities lie in:

Develop personalized medical foods targeting specific genetic profiles. Leverage telehealth platforms for direct-to-consumer medical food sales. Invest in R&D for innovative formulations addressing emerging health trends.

By 2035, the market is poised for robust growth, reflecting evolving consumer needs and technological advancements.

Market Segmentation

Medical Foods Form Outlook

Pills
Powder
Others

Medical Foods Regional Outlook

{"North America"=>["US"
"Canada"]}
{"Europe"=>["Germany"
"France"
"UK"
"Italy"
"Spain"
"Rest of Europe"]}
{"Asia-Pacific"=>["China"
"Japan"
"India"
"Australia"
"South Korea"
"Rest of Asia-Pacific"]}
{"Rest of the World"=>["Middle East"
"Africa"
"Latin America"]}

Medical Foods Application Outlook

Chronic Kidney Disease
Nutritional Deficiency
Neurological & Psychological Disorders
Metabolic Disorders
Pain Management
Gastrointestinal Disorders
Orphan diseases
Others

Medical Foods Distribution Channel Outlook

E-commerce
Hospital Pharmacies
Retail Pharmacies
Others

Medical Foods Nutritional Ingredients Outlook

Vitamins and Minerals
Proteins
Omega-3
Isoflavones
Phytosterols
Others

Medical Foods Route of Administration Outlook

Oral
Enteral

Report Scope

Attribute/Metric	Details
Market Size 2023	USD 22.62 billion
Market Size 2024	USD 24.04 billion
Market Size 2032	USD 35.3 billion
Compound Annual Growth Rate (CAGR)	4.92% (2023-2032)
Base Year	2023
Forecast Period	2024-2032
Historical Data	2018-2022
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Nutritional Ingredients, Route of Administration, Form, Application, Distribution Channel, and, and Region
Geographies Covered	North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered	The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled	Danone SA (France), Abbott (US), Fresenius Kabi AG (Germany), TARGETED MEDICAL PHARMA INC (US), Metagenics LLC (US), Nestlé (Switzerland), Reckitt Benckiser Group PLC (UK), Medtrition, Inc (US), Primus Pharmaceuticals, Inc (US), and Alfasigma USA, Inc (US)
Key Market Opportunities	Increasing product launch initiatives and constant innovations in developing products
Key Market Dynamics	Increasing prevalence of chronic diseasesGrowing nutritional deficiency among peopleRaising awareness about prebiotics and probiotic products

Market Highlights

Author

Rahul Gotadki

Assistant Manager

She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Latest Comments

John Doe

john@example.com

This is a great article! Really helped me understand the topic better.

Posted on July 23, 2025, 10:15 AM

Jane Smith

jane@domain.com

Thanks for sharing this. I’ve bookmarked it for later reference.

Posted on July 22, 2025, 7:45 PM

View All

FAQs

How much is the medical foods market?

The Medical Foods Market is anticipated to reach 35.3 billion at a CAGR of 4.92% during the forecast period of 2024-2032.

How big is the US medical foods market?

The US is expected to hold a 77.44% share of the North America market for medical foods market during the forecast period of 2024-2032.

What is the growth rate of the medical foods market?

The medical foods market is expected to grow at a 4.92% CAGR during the forecast period from 2024 to 2032.

Which region held the largest market share in the medical foods market?

The North America region market held the largest market share in the medical foods market.

Who are the key players in the medical foods market?

The key players include Danone SA (France), Abbott (US), Fresenius Kabi AG (Germany), TARGETED MEDICAL PHARMA INC (US), Metagenics LLC (US), Nestlé (Switzerland), Reckitt Benckiser Group PLC (UK), Medtrition, Inc (US), Primus Pharmaceuticals, inc (US), and Alfasigma USA, Inc (US).

Which application led the medical foods market?

The nutritional deficiency segment was estimated to lead the medical foods market.

Which distribution channel had the largest market share in the medical foods market?

The hospital pharmacies segment is attributed to having the largest market share based on distribution channel.

--- '
Table of Contents
Executive Summary
Market Introduction
1. DEFINITION
2. Scope of the Study
3. RESEARCH OBJECTIVE
4. LIST OF ASSUMPTIONS & LIMITATIONS
Research Methodology
1. DATA MINING
2. SECONDARY RESEARCH
3. PRIMARY RESEARCH
  1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  2. BREAKDOWN OF PRIMARY RESPONDENTS
4. FORECASTING TECHNIQUES
5. Research Methodology FOR MARKET SIZE ESTIMATION
  1. Bottom-up Approach
  2. TOP-DOWN APPROACH
6. DATA TRIANGULATION
7. VALIDATION
MARKET DYNAMICS
1. OVERVIEW
2. DRIVERS
  1. INCREASING PREVALENCE OF CHRONIC DISEASES
  2. GROWING NUTRITIONAL DEFICIENCY AMONG PEOPLE
  3. RAISING AWARENESS ABOUT PREBIOTICS AND PROBIOTIC PRODUCTS
3. RESTRAINTS
  1. LACK OF AWARENESS REGARDING MEDICAL FOOD
4. OPPORTUNITIES
  1. INCREASING PRODUCT LAUNCH INITIATIVES AND CONSTANT INNOVATIONS IN DEVELOPING PRODUCTS
MARKET FACTOR ANALYSIS
1. VALUE CHAIN ANALYSIS
  1. R&D
  2. MANUFACTURING
  3. DISTRIBUTION & SALES
  4. POST-SALES MONITORING
2. PORTER''S FIVE FORCES MODEL
  1. THREAT OF NEW ENTRANTS
  2. BARGAINING POWER OF SUPPLIERS
  3. THREAT OF SUBSTITUTES
  4. BARGAINING POWER OF BUYERS
  5. INTENSITY OF RIVALRY
3. IMPACT OF COVID-19 ON THE GLOBAL MEDICAL FOODS MARKET
  1. IMPACT ON SUPPLY CHAIN
  2. IMPACT ON PRODUCTION
  3. IMPACT ON MARKET PLAYERS
GLOBAL MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS
1. OVERVIEW
2. VITAMINS AND MINERALS
3. PROTEINS
4. OMEGA-3
5. ISOFLAVONES
6. PHYTOSTEROLS
7. OTHERS
GLOBAL MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION
1. OVERVIEW
2. ORAL
3. ENTERAL
GLOBAL MEDICAL FOODS MARKET, BY FORM
1. OVERVIEW
2. PILLS
3. POWDER
4. OTHERS
GLOBAL MEDICAL FOODS MARKET, BY APPLICATION
1. OVERVIEW
2. CHRONIC KIDNEY DISEASE
3. NUTRITIONAL DEFICIENCY
4. NEUROLOGICAL & PSYCHOLOGICAL DISORDERS
5. METABOLIC DISORDERS
6. PAIN MANAGEMENT
7. GASTROINTESTINAL DISORDERS
8. ORPHAN DISEASES
9. OTHERS
GLOBAL MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL
1. OVERVIEW
2. E-COMMERCE
3. HOSPITAL PHARMACIES
4. RETAIL PHARMACIES
5. OTHERS
MEDICAL FOODS MARKET, BY REGION
1. OVERVIEW
2. NORTH AMERICA
  1. US
  2. CANADA
3. EUROPE
  1. GERMANY
  2. UK
  3. FRANCE
  4. ITALY
  5. SPAIN
  6. REST OF EUROPE
4. ASIA-PACIFIC
  1. JAPAN
  2. CHINA
  3. INDIA
  4. SOUTH KOREA
  5. AUSTRALIA
  6. REST OF ASIA-PACIFIC
5. REST OF THE WORLD
  1. MIDDLE EAST
  2. AFRICA
  3. LATIN AMERICA
Competitive Landscape
1. OVERVIEW
2. COMPETITIVE BENCHMARKING
3. MAJOR GROWTH STRATEGY IN THE GLOBAL MEDICAL FOODS MARKET
4. THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL MEDICAL FOODS MARKET
5. KEY DEVELOPMENT ANALYSIS
6. KEY DEVELOPMENTS & GROWTH STRATEGIES
  1. PRODUCT LAUNCH/PRODUCT APPROVAL
  2. MERGER/ACQUISITION
  3. EXPANSION/ INVESTMENT
7. MAJOR PLAYERS SALES ANALYSIS
8. MAJOR PLAYERS R&D ANALYSIS
COMPANY PROFILES
1. DANONE SA
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. SWOT ANALYSIS
  6. KEY STRATEGIES
2. ABBOTT
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. SWOT ANALYSIS
  6. KEY STRATEGIES
3. FRESENIUS KABI AG
  1. COMPANY OVERVIEW
  2. PRODUCTS OFFERED
  3. KEY DEVELOPMENTS
  4. SWOT ANALYSIS
  5. KEY STRATEGIES
4. TARGETED MEDICAL PHARMA INC
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. KEY STRATEGIES
5. METAGENICS LLC
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. KEY STRATEGIES
6. NESTLÉ
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. SWOT ANALYSIS
  6. KEY STRATEGIES
7. RECKITT BENCKISER GROUP PLC
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. SWOT ANALYSIS
  6. KEY STRATEGIES
8. MEDTRITION, INC
  1. COMPANY OVERVIEWS
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. KEY STRATEGIES
9. PRIMUS PHARMACEUTICALS, INC
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. KEY STRATEGIES
10. ALFASIGMA USA, INC
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTSS
  5. KEY STRATEGIES
APPENDIX
1. REFERENCES
2. RELATED REPORTS
List of Tables and Figures
1. LIST OF TABLES
2. TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
3. TABLE 2 GLOBAL MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
4. TABLE 3 GLOBAL MEDICAL FOODS MARKET, FOR VITAMINS AND MINERALS, BY REGION, 2019–2030 (USD BILLION)
5. TABLE 4 GLOBAL MEDICAL FOODS MARKET, FOR PROTEINS, BY REGION, 2019–2030 (USD BILLION)
6. TABLE 5 GLOBAL MEDICAL FOODS MARKET, FOR OMEGA-3, BY REGION, 2019–2030 (USD BILLION)
7. TABLE 6 GLOBAL MEDICAL FOODS MARKET, FOR ISOFLAVONES, BY REGION, 2019–2030 (USD BILLION)
8. TABLE 7 GLOBAL MEDICAL FOODS MARKET, FOR PHYTOSTEROLS, BY REGION, 2019–2030 (USD BILLION)
9. TABLE 8 GLOBAL MEDICAL FOODS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)
10. TABLE 9 GLOBAL MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
11. TABLE 10 GLOBAL MEDICAL FOODS MARKET, FOR ORAL, BY REGION, 2019–2030 (USD BILLION)
12. TABLE 11 GLOBAL MEDICAL FOODS MARKET, FOR ENTERAL, BY REGION, 2019–2030 (USD BILLION)
13. TABLE 12 GLOBAL MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
14. TABLE 13 GLOBAL MEDICAL FOODS MARKET, FOR PILLS, BY REGION, 2019–2030 (USD BILLION)
15. TABLE 14 GLOBAL MEDICAL FOODS MARKET, FOR POWDER, BY REGION, 2019–2030 (USD BILLION)
16. TABLE 15 GLOBAL MEDICAL FOODS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)
17. TABLE 16 GLOBAL MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
18. TABLE 17 GLOBAL MEDICAL FOODS MARKET, FOR CHRONIC KIDNEY DISEASE, BY REGION, 2019–2030 (USD BILLION)
19. TABLE 18 GLOBAL MEDICAL FOODS MARKET, FOR NUTRITIONAL DEFICIENCY, BY REGION, 2019–2030 (USD BILLION)
20. TABLE 19 GLOBAL MEDICAL FOODS MARKET, FOR NEUROLOGICAL & PSYCHOLOGICAL DISORDERS, BY REGION, 2019–2030 (USD BILLION)
21. TABLE 20 GLOBAL MEDICAL FOODS MARKET, FOR METABOLIC DISORDERS, BY REGION, 2019–2030 (USD BILLION)
22. TABLE 21 GLOBAL MEDICAL FOODS MARKET, FOR PAIN MANAGEMENT, BY REGION, 2019–2030 (USD BILLION)
23. TABLE 22 GLOBAL MEDICAL FOODS MARKET, FOR GASTROINTESTINAL DISORDERS, BY REGION, 2019–2030 (USD BILLION)
24. TABLE 23 GLOBAL MEDICAL FOODS MARKET, FOR ORPHAN DISEASES, BY REGION, 2019–2030 (USD BILLION)
25. TABLE 24 GLOBAL MEDICAL FOODS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)
26. TABLE 25 GLOBAL MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
27. TABLE 26 GLOBAL MEDICAL FOODS MARKET, FOR E-COMMERCE, BY REGION, 2019–2030 (USD BILLION)
28. TABLE 27 GLOBAL MEDICAL FOODS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019–2030 (USD BILLION)
29. TABLE 28 GLOBAL MEDICAL FOODS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019–2030 (USD BILLION)
30. TABLE 29 GLOBAL MEDICAL FOODS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)
31. TABLE 30 GLOBAL: MEDICAL FOODS MARKET, BY REGION, 2019–2030 (USD BILLION)
32. TABLE 31 NORTH AMERICA: MEDICAL FOODS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)
33. TABLE 32 NORTH AMERICA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
34. TABLE 33 NORTH AMERICA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
35. TABLE 34 NORTH AMERICA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
36. TABLE 35 NORTH AMERICA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
37. TABLE 36 NORTH AMERICA: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
38. TABLE 37 US: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
39. TABLE 38 US: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
40. TABLE 39 US: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
41. TABLE 40 US: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
42. TABLE 41 US: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
43. TABLE 42 CANADA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
44. TABLE 43 CANADA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
45. TABLE 44 CANADA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
46. TABLE 45 CANADA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
47. TABLE 46 CANADA: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
48. TABLE 47 EUROPE: MEDICAL FOODS MARKET, BY REGION, 2019–2030 (USD BILLION)
49. TABLE 48 EUROPE: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
50. TABLE 49 EUROPE: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
51. TABLE 50 EUROPE: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
52. TABLE 51 EUROPE: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
53. TABLE 52 EUROPE: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
54. TABLE 53 GERMANY: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
55. TABLE 54 GERMANY: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
56. TABLE 55 GERMANY: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
57. TABLE 56 GERMANY: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
58. TABLE 57 GERMANY: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
59. TABLE 58 UK: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
60. TABLE 59 UK: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
61. TABLE 60 UK: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
62. TABLE 61 UK: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
63. TABLE 62 UK: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
64. TABLE 63 FRANCE: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
65. TABLE 64 FRANCE: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
66. TABLE 65 FRANCE: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
67. TABLE 66 FRANCE: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
68. TABLE 67 FRANCE: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
69. TABLE 68 ITALY: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
70. TABLE 69 ITALY: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
71. TABLE 70 ITALY: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
72. TABLE 71 ITALY: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
73. TABLE 72 ITALY: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
74. TABLE 73 SPAIN: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
75. TABLE 74 SPAIN: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
76. TABLE 75 SPAIN: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
77. TABLE 76 SPAIN: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
78. TABLE 77 SPAIN: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
79. TABLE 78 REST OF EUROPE: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
80. TABLE 79 REST OF EUROPE: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
81. TABLE 80 REST OF EUROPE: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
82. TABLE 81 REST OF EUROPE: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
83. TABLE 82 REST OF EUROPE: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
84. TABLE 83 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)
85. TABLE 84 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
86. TABLE 85 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
87. TABLE 86 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
88. TABLE 87 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
89. TABLE 88 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
90. TABLE 89 JAPAN: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
91. TABLE 90 JAPAN: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
92. TABLE 91 JAPAN: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
93. TABLE 92 JAPAN: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
94. TABLE 93 JAPAN: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
95. TABLE 94 CHINA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
96. TABLE 95 CHINA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
97. TABLE 96 CHINA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
98. TABLE 97 CHINA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

Medical Foods Market Segmentation

Market Segmentation Overview

Detailed segmentation data will be available in the full report
Comprehensive analysis by multiple parameters
Regional and country-level breakdowns
Market size forecasts by segment

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027